FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q64235103> ?p ?o ?g. }

• Q64235103 description "article scientifique publié en 2019" @default.
• Q64235103 description "im Januar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
• Q64235103 description "scholarly article by Ernest Choy et al published 2019 in RMD open" @default.
• Q64235103 description "wetenschappelijk artikel" @default.
• Q64235103 description "наукова стаття, опублікована у 2019" @default.
• Q64235103 name "Evaluation of the efficacy and safety of sarilumab combination therapy in patients with rheumatoid arthritis with inadequate response to conventional disease-modifying antirheumatic drugs or tumour necrosis factor α inhibitors: systematic literature" @default.
• Q64235103 name "Evaluation of the efficacy and safety of sarilumab combination therapy in patients with rheumatoid arthritis with inadequate response to conventional disease-modifying antirheumatic drugs or tumour necrosis factor α inhibitors: systematic literature" @default.
• Q64235103 type Item @default.
• Q64235103 label "Evaluation of the efficacy and safety of sarilumab combination therapy in patients with rheumatoid arthritis with inadequate response to conventional disease-modifying antirheumatic drugs or tumour necrosis factor α inhibitors: systematic literature" @default.
• Q64235103 label "Evaluation of the efficacy and safety of sarilumab combination therapy in patients with rheumatoid arthritis with inadequate response to conventional disease-modifying antirheumatic drugs or tumour necrosis factor α inhibitors: systematic literature" @default.
• Q64235103 prefLabel "Evaluation of the efficacy and safety of sarilumab combination therapy in patients with rheumatoid arthritis with inadequate response to conventional disease-modifying antirheumatic drugs or tumour necrosis factor α inhibitors: systematic literature" @default.
• Q64235103 prefLabel "Evaluation of the efficacy and safety of sarilumab combination therapy in patients with rheumatoid arthritis with inadequate response to conventional disease-modifying antirheumatic drugs or tumour necrosis factor α inhibitors: systematic literature" @default.
• Q64235103 P1433 Q64235103-42C529B6-C416-4E9C-867C-0DEDC2A6093C @default.
• Q64235103 P1476 Q64235103-95C0011B-E3F1-43F0-8B3D-D2B5D38DD0F7 @default.
• Q64235103 P2093 Q64235103-147427AF-5B6B-4693-8B6A-EBD5865E6D4F @default.
• Q64235103 P2093 Q64235103-17984A4B-C237-40D1-AAFA-5A932A857DDB @default.
• Q64235103 P2093 Q64235103-2AD77C05-3690-46A1-A2E6-9BDC2DA4BE0A @default.
• Q64235103 P2093 Q64235103-4B46BB79-582D-46C3-80C7-3182B70ED938 @default.
• Q64235103 P2093 Q64235103-649D467A-FA24-471D-B1E7-86A5A5C59A2D @default.
• Q64235103 P2093 Q64235103-90412F84-1415-44AA-856C-AF1B64CF6DF7 @default.
• Q64235103 P2093 Q64235103-B5976678-E1CA-4AFD-98D1-249F2F454C6B @default.
• Q64235103 P2093 Q64235103-CD143005-CC80-4A2B-891F-A0D8CA4F8F7A @default.
• Q64235103 P2093 Q64235103-D889AD42-1CC8-448A-A842-7BEB00D9A228 @default.
• Q64235103 P2093 Q64235103-F1253BE7-F00D-4916-8A00-A639585E9832 @default.
• Q64235103 P2860 Q64235103-092DC8CB-C019-4FBB-80CD-237E21497AA7 @default.
• Q64235103 P2860 Q64235103-0B9D4A1B-D5A3-4C00-BA98-A23DACF855AC @default.
• Q64235103 P2860 Q64235103-1325B89E-F863-44C7-BB32-82DCE6802D0C @default.
• Q64235103 P2860 Q64235103-146BC894-D5DC-40CC-BA22-1D550FB77B65 @default.
• Q64235103 P2860 Q64235103-1560BD0A-B1D0-4BAB-87AF-86879AAA4A4B @default.
• Q64235103 P2860 Q64235103-22A8E4DF-AE43-4CC4-AEE0-92B12411F856 @default.
• Q64235103 P2860 Q64235103-244B6783-2981-4800-8EB9-BCEA4C61E2FC @default.
• Q64235103 P2860 Q64235103-27B8E3B2-5DB4-4520-911B-EAB2DD7C9383 @default.
• Q64235103 P2860 Q64235103-28BA99F8-6777-4861-822E-1A1BD65CCFB3 @default.
• Q64235103 P2860 Q64235103-31474764-F9A3-427D-9260-D3E65D24075F @default.
• Q64235103 P2860 Q64235103-3DE26E87-79E0-4D47-AE69-D577B1AA04EB @default.
• Q64235103 P2860 Q64235103-47D14F72-8556-4583-A1CD-035122C7BA0F @default.
• Q64235103 P2860 Q64235103-496DD966-0170-47E2-A600-2B658C55A653 @default.
• Q64235103 P2860 Q64235103-562DFAA9-9773-4BD7-96EE-F329553C60A9 @default.
• Q64235103 P2860 Q64235103-621FCE7D-2DE6-43CD-B185-CF1FF6DE3DEF @default.
• Q64235103 P2860 Q64235103-62CB0F60-9D4B-4CD3-905E-E05D2F9DAE16 @default.
• Q64235103 P2860 Q64235103-6BC5BD2D-6AF0-4ABA-981D-DEE8902E9600 @default.
• Q64235103 P2860 Q64235103-6F9C84C2-14C9-47B6-B079-F2A78ED98FE5 @default.
• Q64235103 P2860 Q64235103-726A2D9D-1B44-4E07-9DF0-6E106695AE0C @default.
• Q64235103 P2860 Q64235103-729EDFD6-3952-429B-BD56-680712B0FB72 @default.
• Q64235103 P2860 Q64235103-72A1A070-F276-4C7E-B352-952AEA2C4F72 @default.
• Q64235103 P2860 Q64235103-7CD92642-7826-4031-9AF7-B64E70AE1D76 @default.
• Q64235103 P2860 Q64235103-8F4C4666-1DDA-4695-9E08-DB014C02EADB @default.
• Q64235103 P2860 Q64235103-BCA489F9-D954-4A71-B672-0B41BFBC6320 @default.
• Q64235103 P2860 Q64235103-BF30A9F3-9E46-44F3-BA4A-A56C981E2CD5 @default.
• Q64235103 P2860 Q64235103-BFFB7B47-0165-45EF-9A2A-FC1BD4BF8EB8 @default.
• Q64235103 P2860 Q64235103-C4AF1D59-D002-4BB5-BE4A-B16F8E674347 @default.
• Q64235103 P2860 Q64235103-DC4F2312-4985-4BE8-9575-611B8CB0F3C7 @default.
• Q64235103 P2860 Q64235103-DF8BD8BF-D0B8-48DD-84C2-D2DD6C97D344 @default.
• Q64235103 P2860 Q64235103-DFD2080A-4ACA-4156-AE7F-7B7BEC908883 @default.
• Q64235103 P2860 Q64235103-EBD5D03D-C4DE-41FD-B93E-86A888846C34 @default.
• Q64235103 P2860 Q64235103-F0A5215C-259A-4958-97FE-4776CF912C8E @default.
• Q64235103 P2860 Q64235103-F44520D6-5477-4711-A341-D8432123714B @default.
• Q64235103 P2860 Q64235103-FDD2D822-8227-4982-8148-09E4FD9F6CCE @default.
• Q64235103 P304 Q64235103-AD92E9F8-F036-4B04-AF23-864CE5601938 @default.
• Q64235103 P31 Q64235103-30E75570-DF63-47D6-B913-7DAF5564C38F @default.
• Q64235103 P31 Q64235103-3b0bb3d2-4773-4067-9b14-64027fbaf2dc @default.
• Q64235103 P356 Q64235103-9410F9F3-BAE6-4415-A2C8-E7D91775EF92 @default.
• Q64235103 P407 Q64235103-F82C3A62-E6F9-4323-B54F-4B82077CDF5E @default.
• Q64235103 P433 Q64235103-911A91BE-D6D1-42FF-B1DE-2998F9507F84 @default.
• Q64235103 P478 Q64235103-EA90765C-AC7B-483F-8B0E-7005C9031F0B @default.
• Q64235103 P577 Q64235103-68EDE4A5-EB71-4AA3-9E1B-F0BD6FCCCB5B @default.
• Q64235103 P698 Q64235103-E4F29470-2939-4E23-9E10-BE67A4332050 @default.
• Q64235103 P921 Q64235103-4A6E94B7-BB36-4EDF-A74F-7EE96A6B87F1 @default.
• Q64235103 P921 Q64235103-A6704CE4-ADD6-4AEE-B39E-1F2B1F574EC3 @default.
• Q64235103 P932 Q64235103-7CBD5AD0-ED46-40EA-B5AF-FBD5007253A0 @default.
• Q64235103 P356 RMDOPEN-2018-000798 @default.
• Q64235103 P698 30886733 @default.
• Q64235103 P1433 Q27726913 @default.
• Q64235103 P1476 "Evaluation of the efficacy and safety of sarilumab combination therapy in patients with rheumatoid arthritis with inadequate response to conventional disease-modifying antirheumatic drugs or tumour necrosis factor α inhibitors: systematic literature" @default.
• Q64235103 P2093 "Andreas Kuznik" @default.
• Q64235103 P2093 "Chieh-I Chen" @default.
• Q64235103 P2093 "Clare Proudfoot" @default.
• Q64235103 P2093 "Erin Mangan" @default.
• Q64235103 P2093 "Ernest Choy" @default.
• Q64235103 P2093 "Hubert Van Hoogstraten" @default.
• Q64235103 P2093 "Laurence Pollissard" @default.
• Q64235103 P2093 "Nick Freemantle" @default.
• Q64235103 P2093 "Paulo Carita" @default.
• Q64235103 P2093 "Thi-Minh-Thao Huynh" @default.
• Q64235103 P2860 Q24289190 @default.
• Q64235103 P2860 Q28750315 @default.
• Q64235103 P2860 Q29619499 @default.
• Q64235103 P2860 Q29619501 @default.
• Q64235103 P2860 Q34081552 @default.
• Q64235103 P2860 Q34465354 @default.
• Q64235103 P2860 Q34500921 @default.
• Q64235103 P2860 Q34547981 @default.
• Q64235103 P2860 Q35637985 @default.
• Q64235103 P2860 Q36023494 @default.
• Q64235103 P2860 Q36610390 @default.
• Q64235103 P2860 Q36991744 @default.
• Q64235103 P2860 Q37233468 @default.
• Q64235103 P2860 Q37465523 @default.
• Q64235103 P2860 Q37888895 @default.
• Q64235103 P2860 Q38510678 @default.

• next